We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Bausch + Lomb points recall of enVista lenses utilized in cataract surgical procedure
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Bausch + Lomb points recall of enVista lenses utilized in cataract surgical procedure
Bausch + Lomb points recall of enVista lenses utilized in cataract surgical procedure
Health

Bausch + Lomb points recall of enVista lenses utilized in cataract surgical procedure

Last updated: April 10, 2025 9:42 pm
Editorial Board Published April 10, 2025
Share
SHARE

Bausch + Lomb has introduced a voluntary recall of intraocular lenses on its enVista platform as a result of potential for an acute postoperative inflammatory response.

All numerous the next intraocular lens fashions in the USA are included within the recall: enVista Aspire, enVista Aspire Toric, enVista Envy, and enVista Envy Toric, in addition to enVista monofocal and enVista monofocal Toric.

The recall was issued in response to stories of poisonous anterior section syndrome, or TASS, an acute sterile anterior chamber inflammatory response that normally develops 12 to 48 hours after surgical procedure. All sufferers with reported instances of TASS as a result of enVista lenses responded rapidly to therapy. No sufferers wanted to have the lenses eliminated. Bausch + Lomb continues to be investigating the reason for the issues reported.

“As much as we believe in the enVista platform, patient safety will always be our number one priority. Surgeons and patients trust Bausch + Lomb, and I believe that this voluntary recall is the best thing we can do to honor that trust,” Brent Saunders, chairman and CEO of Bausch + Lomb, mentioned in a press release. “These reports represent only 1 to 2% of implanted lenses, with a positive prognosis for everyone involved. We look forward to identifying a root cause and bringing the enVista platform back to market.”

Sufferers who’ve undergone cataract surgical procedure ought to contact their eye care skilled instantly in the event that they expertise eye discomfort. In the meantime, eye care professionals ought to proceed to carefully monitor cataract surgical procedure sufferers for not less than 48 hours after surgical procedure and instruct sufferers to name the workplace instantly in the event that they develop new or worsening signs.

Extra data:
Extra Data

2025 HealthDay. All rights reserved.

Quotation:
Bausch + Lomb points recall of enVista lenses utilized in cataract surgical procedure (2025, April 10)
retrieved 10 April 2025
from https://medicalxpress.com/information/2025-04-bausch-lomb-issues-recall-envista.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

Can psychedelic mushrooms flip again the clock? Examine suggests psilocybin preserves telomere size

Research uncovers key RNA-driven community behind colorectal most cancers development and immune response

NRTI use linked to danger for main open-angle glaucoma

Pores and skin-to-skin contact with infants elevated considerably after coaching

On-line ballot reveals Individuals cannot inform wholesome processed meals from unhealthy ones

TAGGED:BauschcataractenVistaissuesLensesLombrecallsurgery
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Researchers goal to cut back avoidable hospitalizations for nursing house residents with dementia
Health

Researchers goal to cut back avoidable hospitalizations for nursing house residents with dementia

Editorial Board January 4, 2025
What to Wear in the Metaverse
Invoice Madden: Credit score to Yankees GM Brian Cashman for creating homegrown expertise and discovering unsung heroes
2,770 instances of arboviral illness reported in 48 states and D.C. in 2023
Chloe Kim Is Grown Up and Ready for the Olympic Spotlight

You Might Also Like

Frequent autoimmune drug might assist reverse immunotherapy-induced diabetes
Health

Frequent autoimmune drug might assist reverse immunotherapy-induced diabetes

July 8, 2025
Treating postoperative delirium as preventable ‘acute mind failure’: Low-cost interventions may have main impression
Health

Treating postoperative delirium as preventable ‘acute mind failure’: Low-cost interventions may have main impression

July 8, 2025
Dementia safety linked to the place the physique lies—stomach fats a threat issue
Health

Dementia safety linked to the place the physique lies—stomach fats a threat issue

July 8, 2025
An even bigger waist could enhance the chance of dying for older girls
Health

An even bigger waist could enhance the chance of dying for older girls

July 8, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?